Anti-MAG neuropathy is a demyelinating neuropathy mediated by a monoclonal IgM antibody that binds to MAG protein and, different from CIDP, is not considered an inflammatory disease, and therefore, typical CIDP treatments are usually only transiently effective in these patients. Here, MAG is linked to chronic inflammatory demyelinating polyradiculoneuropathy.